Chemo-Free Maintenance Combo Promising in Pancreatic Cancer

Niraparib-ipilimumab combination yields 6-month progression-free survival rate of 60%

Related Keywords

Italy ,University Of Pennsylvania ,Pennsylvania ,United States ,Milan ,Lombardia ,Massachusetts ,Philadelphia ,Kima Reiss ,Michele Reni ,Mike Bassett ,Giulia Orsi ,San Raffaele Scientific Institute ,Vitae Salute University ,Perelman School Of Medicine ,Perelman School ,Salute University ,